Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × cositecan × Clear all

NCT00054119 2017-07-13

Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Phase 2 Completed

Ovarian Neoplasms